SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Developing Nations, Including India, Capable of Producing Lower-Cost HPV Vaccine

By

By:  Tanya Thomas on  July 12, 2010 at 10:39 AM Vaccine manufacturers in India and other developing nations can produce a lower-cost HPV vaccine despite the complicated array of patent protections on the technology, according to an Indian-origin scientist at the Duke Institute for Genome Sciences and Policy. At a cost of at least 300dollars […]

A Judicial Watch Special Report: Examining the FDA’s HPV Vaccine Records

By

Detailing the Approval Process, Side-Effects, Safety Concerns and Marketing Practices of a Large-Scale Public Health Experiment June 30, 2008   This Judicial Watch Special Report is an analysis of records obtained from the Food and Drug Administration (FDA) concerning a recent vaccine called Gardasil. Gardasil helps protect against four types of human papillomavirus (HPV). The […]

Gardasil Blood Clots Are A Potential Risk Associated With Gardasil

By

30.07.2010 | Author: vaccineinjuryhelpcenter | Posted in Health & Fitness Gardasil blood clots and other serious side effects have been associated with Gardasil. Gardasil is a vaccine designed to prevent certain types of human papillomavirus (HPV). These HPV types are associated with a great percentage of cervical cancer cases as well as a smaller percentage of […]

Caution Urged Over Large-Scale HPV Vaccination Programs

By

By:  Zosia Chustecka From Medscape Medical News   August 20, 2008 — “There is good reason to be cautious about introducing large-scale vaccination programs” with the human papillomavirus (HPV) vaccines, because many essential questions are still unanswered. This is the conclusion of Charlotte Haug, MD, PhD, from the Journal of the Norwegian Medical Association, in […]

Anaphylaxis following quadrivalent human papillomavirus vaccination.

By

By:  Julia M.L. Brotherton, MD HPH, et al Published at www.cmaj.ca on Sept. 1, 2008.   Background:  In 2007, Australia implemented the National human papillomavirus (HPV) Vaccination Program, which provides quadrivalent HPV vaccine free to all women aged 12–26 years. Following notification of 7 presumptive cases of anaphylaxis in the state of New South Wales, […]

News

Videos

Contact